Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

388243

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Allergies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with clinical and research bodies on methods of reducing the number of people who develop allergies.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5886
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>Although health is a devolved matter, research and evidence on best practice is made widely available across the United Kingdom health departments.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/07/2015 13:20:26 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

388244

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on complications experienced by some patients including pain and difficulty swallowing food after weight-loss surgery; and what steps he plans to take in response to those representations.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5887
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The National Registry for Bariatric Surgery collects a range of outcomes data including complications through the national clinical reference group. However, commissioners do not ask for data on these specific symptoms.</p><p> </p><p> </p><p> </p><p>If a patient experiences post-surgical issues they should seek advice from their doctor. The symptoms described can occur after any type of gastric surgery and are not necessarily related to surgery specific for obesity.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/07/2015 14:09:55 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

388245

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans NHS England has to make biphosphorates available as a treatment to prevent breast cancer spreading into bones.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5888
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>Clinicians are able to prescribe bisphosphonates for the prevention of breast cancer where there is a clinical need.</p><p> </p><p> </p><p> </p><p>NHS England’s breast cancer clinical reference group has highlighted bisphosphonates as a key issue for potential improvement in survival outcomes in its draft service specification for breast cancer.</p><p> </p><p> </p><p> </p><p>NHS England expects the draft service specification to be finalised and available for dissemination in autumn 2015. It will then be up to clinical commissioning groups to take this into account in developing their local commissioning activities.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/07/2015 16:48:01 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

388246

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will assess the potential merits of introducing routine follow-up checks for people who have received negative results when tested for cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5889
answer	answer is ministerial correction date of answer 15/07/2015 answer text <p>Increasing the capacity of diagnostic and imaging services is clearly recognised as a priority for the National Health Service and it has been raised as a key issue by the independent Cancer Taskforce, as well as by the Cancer Waiting Times Taskforce. We expect a new cancer strategy to be published later this month which will set out the strategy for the system for the next five years and will include consideration of the whole cancer pathway, including the capacity of diagnostic services. However, we are not aware of any specific plans to introduce follow-up checks for people who have received negative results when tested for cancer.</p><p> </p><p> </p><p> </p><p>NHS England has launched a major early diagnosis programme (Accelerate, Co-ordinate, Evaluate – ACE), working jointly with Cancer Research UK and Macmillan Cancer Support to test new innovative approaches to identifying cancer more quickly, including offering patients the option to self-refer for diagnostic tests.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/07/2015 14:26:39 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

388247

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Depressive Illnesses: Isotretinoin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with clinical and pharmaceutical bodies on alleged links between the acne drug roaccutane and depression.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5890
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The Medicines and Healthcare products Regulatory Agency has met with various stakeholders regarding the possible link between Roaccutane (isotretinoin) and psychiatric disorders including depression since the late 1990’s.</p><p> </p><p> </p><p> </p><p>Warnings regarding the possible risk of developing depression or aggravating existing depression have been included in the product information for Roaccutane and the generic versions of isotretinoin since 1998. As further data has emerged the warnings have been updated.</p><p> </p><p> </p><p> </p><p>A scientific advisory group of the Commission on Human Medicines (CHM), the Government’s independent expert advisory body on medicines licensing and safety, was first convened in 2003 to specifically consider the safety of isotretinoin.</p><p> </p><p> </p><p> </p><p>The members of the group included experts in clinical pharmacology, pharmacovigilance, dermatology, psychiatry, psychopharmacology, epidemiology and general practice, as well as lay members. The group considered the risks of psychiatric disorders including depression suspected to be associated with isotretinoin in 2003, 2005 and 2014 and reported their findings to the CHM.</p><p> </p><p> </p><p> </p><p>The recommendations of the expert group were endorsed by CHM and were communicated to healthcare professionals, including clinicians and pharmacists.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/07/2015 16:00:58 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

388282

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cataracts: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many cataract operations have been conducted for people in each age group in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	6040
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The number of cataract operations in England over the last five years are shown in the attached table. In 2013-14 there were 365,470. This compares to 343,970 operations in 2009-10. The 70-79 and 80-89 age groups had the largest number of operations accounting for 68% of cataract operations in 2013-14.</p><p><br><br></p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 14/07/2015 16:45:52 answering member 1201 label Biography information for Alistair Burt attachment 1 file name Cataract Operations 2009-14.docx title Cataract operations (England) per age group 09-14
tabling member	4131 label Biography information for Jim Shannon

388286

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people were diagnosed with Ehlers-Danlos syndrome in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	6037
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The Department does not hold this information centrally.</p><p> </p><p> </p><p> </p><p>Ehlers-Danlos Syndrome (EDS) is a complex group of heritable disorders of connective tissue with an estimated prevalence of 1 in 20,000. As EDS appears in a variety of forms diagnosis can be underestimated.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/07/2015 13:15:27 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

388287

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Visual Impairment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in each age group were registered as blind in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	6038
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>Information on the number of people who are registered as blind or deaf is collected and published by the Health and Social Care Information Centre.</p><p> </p><p> </p><p> </p><p>The following table shows the last available information related to the age distribution for people registered as deaf in England:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>All</p></td><td><p>under 18</p></td><td><p>18 - 64</p></td><td><p>65 - 74</p></td><td><p>75 and over</p></td></tr><tr><td><p>2007</p></td><td><p>54,500</p></td><td><p>3,400</p></td><td><p>28,700</p></td><td><p>6,400</p></td><td><p>16,000</p></td></tr><tr><td><p>2010</p></td><td><p>56,400</p></td><td><p>2,200</p></td><td><p>30,100</p></td><td><p>6,700</p></td><td><p>17,400</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The table below shows the latest available information related to the age distribution for people registered as blind in the last five years:</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Type</p></td><td><p>All</p></td><td><p>under 18</p></td><td><p>18 - 49</p></td><td><p>50 - 74</p></td><td><p>75 and over</p></td></tr><tr><td><p>2008</p></td><td><p>All cases</p></td><td><p>152,980</p></td><td><p>4,780</p></td><td><p>19,330</p></td><td><p>30,460</p></td><td><p>98,270</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>10,230</p></td><td><p>415</p></td><td><p>880</p></td><td><p>1,800</p></td><td><p>7,130</p></td></tr><tr><td><p>2011</p></td><td><p>All cases</p></td><td><p>147,810</p></td><td><p>4,440</p></td><td><p>18,880</p></td><td><p>29,985</p></td><td><p>94,475</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>9,110</p></td><td><p>405</p></td><td><p>985</p></td><td><p>1,740</p></td><td><p>5,975</p></td></tr><tr><td><p>2014</p></td><td><p>All cases</p></td><td><p>143,385</p></td><td><p>4,275</p></td><td><p>19,570</p></td><td><p>31,620</p></td><td><p>87,920</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>8,875</p></td><td><p>370</p></td><td><p>890</p></td><td><p>1,700</p></td><td><p>5,915</p></td></tr></tbody></table><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 6039 question first answered 14/07/2015 13:38:52 answering member 1201 label Biography information for Alistair Burt
tabling member	4131 label Biography information for Jim Shannon

388288

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hearing Impairment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in each age group were registered as deaf in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	6039
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>Information on the number of people who are registered as blind or deaf is collected and published by the Health and Social Care Information Centre.</p><p> </p><p> </p><p> </p><p>The following table shows the last available information related to the age distribution for people registered as deaf in England:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>All</p></td><td><p>under 18</p></td><td><p>18 - 64</p></td><td><p>65 - 74</p></td><td><p>75 and over</p></td></tr><tr><td><p>2007</p></td><td><p>54,500</p></td><td><p>3,400</p></td><td><p>28,700</p></td><td><p>6,400</p></td><td><p>16,000</p></td></tr><tr><td><p>2010</p></td><td><p>56,400</p></td><td><p>2,200</p></td><td><p>30,100</p></td><td><p>6,700</p></td><td><p>17,400</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The table below shows the latest available information related to the age distribution for people registered as blind in the last five years:</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Type</p></td><td><p>All</p></td><td><p>under 18</p></td><td><p>18 - 49</p></td><td><p>50 - 74</p></td><td><p>75 and over</p></td></tr><tr><td><p>2008</p></td><td><p>All cases</p></td><td><p>152,980</p></td><td><p>4,780</p></td><td><p>19,330</p></td><td><p>30,460</p></td><td><p>98,270</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>10,230</p></td><td><p>415</p></td><td><p>880</p></td><td><p>1,800</p></td><td><p>7,130</p></td></tr><tr><td><p>2011</p></td><td><p>All cases</p></td><td><p>147,810</p></td><td><p>4,440</p></td><td><p>18,880</p></td><td><p>29,985</p></td><td><p>94,475</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>9,110</p></td><td><p>405</p></td><td><p>985</p></td><td><p>1,740</p></td><td><p>5,975</p></td></tr><tr><td><p>2014</p></td><td><p>All cases</p></td><td><p>143,385</p></td><td><p>4,275</p></td><td><p>19,570</p></td><td><p>31,620</p></td><td><p>87,920</p></td></tr><tr><td> </td><td><p>New cases</p></td><td><p>8,875</p></td><td><p>370</p></td><td><p>890</p></td><td><p>1,700</p></td><td><p>5,915</p></td></tr></tbody></table><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 6038 question first answered 14/07/2015 13:38:52 answering member 1201 label Biography information for Alistair Burt
tabling member	4131 label Biography information for Jim Shannon

388289

registered interest
date	07/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to make the HemoLink device for taking blood samples available for use in the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	5933
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>Manufacturers of medical devices have to obtain a CE mark before their products can be made available on the European Union market. The HemoLink device has not yet received a CE mark and therefore cannot be used as a medical device in the European Union. Decisions on the use of particular products that are CE marked are a matter for individual healthcare providers.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/07/2015 14:53:25 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon